Stent Thrombogenicity Early in High Risk Interventional Settings is Driven by Stent Design and Deployment, and Protected by Polymer-Drug Coatings
Author Manuscript: 2012 April 5
Main Authors: | Kolandaivelu, Kumaran, Swaminathan, Rajesh, Gibson, William J., Kolachalama, Vijaya Bhasker, Nguyen-Ehrenreich, Kim-Lien, Giddings, Virginia L., Coleman, Leslie, Wong, Gee K., Edelman, Elazer R. |
---|---|
Other Authors: | Institute for Medical Engineering and Science |
Format: | Article |
Language: | en_US |
Published: |
American Heart Association
2012
|
Online Access: | http://hdl.handle.net/1721.1/75397 https://orcid.org/0000-0003-3159-8175 https://orcid.org/0000-0002-7832-7156 |
Similar Items
-
Luminal flow amplifies stent-based drug deposition in arterial
by: Levine, Evan G., et al.
Published: (2010) -
Luminal Flow Amplifies Stent-Based Drug Deposition in Arterial Bifurcations
by: Kolachalama, Vijaya Bhasker, et al.
Published: (2010) -
In Silico Assessment of the effects of Material on Stent Deployment
by: Conway, Claire, et al.
Published: (2020) -
Impact of flow pulsatility on arterial drug distribution in stent-based therapy
by: O’Brien, Caroline C., et al.
Published: (2014) -
Vascular Response to Experimental Stent Malapposition and Under-Expansion
by: Bailey, Lynn, et al.
Published: (2017)